118 related articles for article (PubMed ID: 25531193)
41. Muscarinic agonists and antagonists: effects on the urinary bladder.
Sellers DJ; Chess-Williams R
Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
[TBL] [Abstract][Full Text] [Related]
42. [A case of neurogenic bladder patient whose pre-void bladder capacity was correlated with the post-void residual volume].
Kuroda S; Noguchi K; Takahashi T; Nakamura M; Kawai M; Murai T; Murai M
Hinyokika Kiyo; 2014 Jun; 60(6):287-90. PubMed ID: 25001645
[TBL] [Abstract][Full Text] [Related]
43. Effects of Silodosin, an α1A-Adrenoceptor Antagonist, and Distigmine, an Acetylcholinesterase Inhibitor, and Their Combined Effects on Impaired Voiding Function in Zucker Diabetic Fatty Rats.
Tatemichi S; Tsuchioka K; Yonekubo S; Maruyama K; Kobayashi M
Pharmacology; 2015; 95(5-6):285-92. PubMed ID: 26023044
[TBL] [Abstract][Full Text] [Related]
44. A further report on the effect of distigmine bromide (Ubretid) on the neurogenic bladder.
Yeo J; Southwell P; Rutowski S; Marchant-Williams H
Med J Aust; 1974 Aug; 2(6):201-3. PubMed ID: 4424051
[No Abstract] [Full Text] [Related]
45. Distigmine bromide and post-prostatectomy voiding.
Shah PJ; Abrams PH; Choa RG; Ashken MH; Gaches CG; Green NA; Wiles A
Br J Urol; 1983 Apr; 55(2):229-32. PubMed ID: 6132645
[TBL] [Abstract][Full Text] [Related]
46. Cholinergic Crisis Owing to Distigmine Bromide Complicated by Hyperosmolar Hyperglycemic State.
Kotake K; Tone A; Watanabe S; Senoo M; Kaneto M; Imai Y; Teshigawara S; Kawakami Y; Nakatou T
Intern Med; 2021 Jul; 60(14):2251-2254. PubMed ID: 33583891
[TBL] [Abstract][Full Text] [Related]
47. Bethanechol for buprenorphine-related urinary hesitancy: a case series.
Varma A; Smigiel J; Eck N; Brooks S
J Addict Med; 2011 Sep; 5(3):227-8. PubMed ID: 21844838
[TBL] [Abstract][Full Text] [Related]
48. Failure of the bethanechol supersensitivity test to predict improved voiding after subcutaneous bethanechol administration.
Wein AJ; Raezer DM; Malloy TR
J Urol; 1980 Feb; 123(2):202-3. PubMed ID: 7354517
[TBL] [Abstract][Full Text] [Related]
49. The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study.
Barrett DM
J Urol; 1981 Nov; 126(5):640-2. PubMed ID: 6117662
[TBL] [Abstract][Full Text] [Related]
50. Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography.
Al-Izki S; Pryce G; Giovannoni G; Baker D
Mult Scler; 2009 Jul; 15(7):795-801. PubMed ID: 19465448
[TBL] [Abstract][Full Text] [Related]
51. [Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker].
Katsumi T; Murayama K
Hinyokika Kiyo; 1992 Sep; 38(9):1089-92. PubMed ID: 1384297
[TBL] [Abstract][Full Text] [Related]
52. Effect of bethanechol, neostigmine, metoclopramide, and propranolol on myoelectric activity of the ileocecocolic area in cows.
Steiner A; Roussel AJ; Martig J
Am J Vet Res; 1995 Aug; 56(8):1081-6. PubMed ID: 8533981
[TBL] [Abstract][Full Text] [Related]
53. Time course of isolated rat fundus response to muscarinic agonists: a measure of intrinsic efficacy.
Jankovic SM; Kouvelas D; Mirtsou-Fidani V
Physiol Res; 1998; 47(6):463-70. PubMed ID: 10453754
[TBL] [Abstract][Full Text] [Related]
54. Bethanechol provocation testing does not predict symptom relief after cholecystectomy for acalculous biliary pain.
Smythe A; Ahmed R; Fitzhenry M; Johnson AG; Majeed AW
Dig Liver Dis; 2004 Oct; 36(10):682-6. PubMed ID: 15506668
[TBL] [Abstract][Full Text] [Related]
55. Pharmaceutical review: Ubretid - beta-carotene.
Martin S
Lamp; 1978 Nov; 35(11):37-9. PubMed ID: 32442
[No Abstract] [Full Text] [Related]
56. Prophylaxis and treatment of bladder dysfunction after Wertheim-Meigs operation: the positive effect of early postoperative detrusor stimulation using the cholinergic drug betanecholchloride.
Kemp B; Kitschke HJ; Goetz M; Heyl W
Int Urogynecol J Pelvic Floor Dysfunct; 1997; 8(3):138-41. PubMed ID: 9449585
[TBL] [Abstract][Full Text] [Related]
57. Effects of glucose deprivation on the contractile response of the rabbit bladder to repetitive stimulation.
Kwon HY; Longhurst PA; Parsons K; Wein AJ; Levin RM
Neurourol Urodyn; 1996; 15(1):71-8. PubMed ID: 8696358
[TBL] [Abstract][Full Text] [Related]
58. Cholinergic activation of phasic activity in the isolated bladder: possible evidence for M3- and M2-dependent components of a motor/sensory system.
Finney SM; Stewart LH; Gillespie JI
BJU Int; 2007 Sep; 100(3):668-78. PubMed ID: 17627783
[TBL] [Abstract][Full Text] [Related]
59. Effects of a peripheral cholinesterase inhibitor on cytokine production and autonomic nervous activity in a rat model of sepsis.
Setoguchi D; Yatsuki H; Sadahiro T; Nakamura M; Hirayama Y; Watanabe E; Tateishi Y; Oda S
Cytokine; 2012 Feb; 57(2):238-44. PubMed ID: 22138106
[TBL] [Abstract][Full Text] [Related]
60. Voiding dysfunction in older women with overactive bladder symptoms: A comparison of urodynamic parameters between women with normal and elevated post-void residual urine.
Park J; Lavelle JP; Palmer MH
Neurourol Urodyn; 2016 Jan; 35(1):95-9. PubMed ID: 25400112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
